Obesity drugmaker Novo Nordisk's Q1 profit beats forecast

Obesity drugmaker Novo Nordisk's Q1 profit beats forecast
  • Country:
  • United Kingdom

Novo Nordisk posted on Thursday first-quarter operating profit above analyst forecasts, as the Danish drugmaker races to boost output of its hugely popular weight-loss drug Wegovy and fend off competition from Eli Lilly.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.